#Gene_Symbol	NCBI_Variation_ID	NCBI_AlleleID	HGVS	Submitter1	Submitter1_ID	Submitter1_SCV	Submitter1_Definition	Submitter1_ClinSig	Submitter1_LastEval	Submitter1_AssertionMethod	Submitter1_Sub_Condition	Submitter1_Calc_Condition	Submitter1_Description	Submitter2	Submitter2_ID	Submitter2_SCV	Submitter2_Definition	Submitter2_ClinSig	Submitter2_LastEval	Submitter2_AssertionMethod	Submitter2_Sub_Condition	Submitter2_Calc_Condition	Submitter2_Description	Rank_diff
BRCA1	37423	45979	NM_007294.3(BRCA1):c.1648A>C (p.Asn550His)	Sharing Clinical Reports Project (SCRP)	SCRP_var_41	SCV000053597		Benign	May  1 2012 12:00:00:000AM	clinical testing	Breast-ovarian cancer, familial 1			CSER_CC_NCGL	UWMG_5813026	SCV000190082	<SequenceLocation Assembly="GRCh37" Chr="17" start="41245900"/>	Likely benign	Jun  1 2014 12:00:00:000AM	research	Breast cancer	Breast cancer		1
MSH6	132772	136520	NM_000179.2(MSH6):c.3173-10C>T	Invitae	NM_000179.2:c.3173-10C>T|MedGen:40399	SCV000153987	NM_000179.2:c.3173-10C>T	Uncertain significance	Jun 11 2014 12:00:00:000AM	clinical testing	Lynch syndrome		This sequence change has not been reported in affected patients, and has not been reported as a common polymorphism in the population. This sequence change falls in intron 4 of the MSH6 mRNA. It does not change the protein sequence and is not predicted to affect splicing, but this prediction has not been confirmed by functional studies.	Ambry Genetics	a60768	SCV000184142	NM_000179.2:c.3173-10C>T	Uncertain significance	Mar 18 2014 12:00:00:000AM	clinical testing	Neoplastic Syndromes, Hereditary	Hereditary cancer-predisposing syndrome		0
BRCA2	132779	136527	NM_000059.3(BRCA2):c.4563A>G (p.Leu1521=)	Counsyl	59625	SCV000154035	NM_000059.3:c.4563A>G	Benign	Jan  2 2014 12:00:00:000AM	literature only	Breast-ovarian cancer, familial 2		High frequency in a 1kG or ESP population: 99.9 %.	GeneDx	GDX:392875|MedGen:C0346153	SCV000167365	NM_000059.3:c.4563A>G	Benign	Nov 13 2013 12:00:00:000AM	clinical testing	Familial cancer of breast	Familial cancer of breast	The variant is found in BRCA1-BRCA2 panel(s).	0
BRCA2	132779	136527	NM_000059.3(BRCA2):c.4563A>G (p.Leu1521=)	Counsyl	59625	SCV000154035	NM_000059.3:c.4563A>G	Benign	Jan  2 2014 12:00:00:000AM	literature only	Breast-ovarian cancer, familial 2		High frequency in a 1kG or ESP population: 99.9 %.	Ambry Genetics	a959	SCV000187248	NM_000059.3:c.4563A>G	Benign	Jul 10 2012 12:00:00:000AM	clinical testing	Neoplastic Syndromes, Hereditary	Hereditary cancer-predisposing syndrome		0
BRCA2	132779	136527	NM_000059.3(BRCA2):c.4563A>G (p.Leu1521=)	Counsyl	59625	SCV000154035	NM_000059.3:c.4563A>G	Benign	Jan  2 2014 12:00:00:000AM	literature only	Breast-ovarian cancer, familial 2		High frequency in a 1kG or ESP population: 99.9 %.	Emory Genetics Laboratory	16512_000000	SCV000202287		Benign	Dec  6 2013 12:00:00:000AM	clinical testing	AllHighlyPenetrant	not specified		0
BRCA2	132780	136528	NM_000059.3(BRCA2):c.6513G>C (p.Val2171=)	Counsyl	59649	SCV000154059	NM_000059.3:c.6513G>C	Benign	Jan  2 2014 12:00:00:000AM	literature only	Breast-ovarian cancer, familial 2	    High frequency in a 1kG or ESP population: 99.9 %.	Emory Genetics Laboratory	16514_000000	SCV000202293		Benign	Dec  6 2013 12:00:00:000AM	clinical testing	AllHighlyPenetrant	not specified		0
BRCA2	132780	136528	NM_000059.3(BRCA2):c.6513G>C (p.Val2171=)	Counsyl	59649	SCV000154059	NM_000059.3:c.6513G>C	Benign	Jan  2 2014 12:00:00:000AM	literature only	Breast-ovarian cancer, familial 2	    High frequency in a 1kG or ESP population: 99.9 %.	GeneDx	GDX:393300|MedGen:C0346153	SCV000167382	NM_000059.3:c.6513G>C	Benign	Jun 23 2014 12:00:00:000AM	clinical testing	Familial cancer of breast	Familial cancer of breast	The variant is found in BRCA1-BRCA2,HEREDICANCER,BR-OV-HEREDIC panel(s).	0
BRCA2	132781	136529	NM_000059.3(BRCA2):c.5418A>G (p.Glu1806=)	Counsyl	165397	SCV000154084	NM_000059.3:c.5418A>G	Benign	Mar 17 2014 12:00:00:000AM	literature only	Breast-ovarian cancer, familial 2			Emory Genetics Laboratory	16513_000000	SCV000202289		Benign	Dec  6 2013 12:00:00:000AM	clinical testing	AllHighlyPenetrant	not specified		0
	132820	136569	NM_007194.3(CHEK2):c.*7T>C	Institute. of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague	NM_007194.3:c.1632+7T>C|BEXO	SCV000154114	NM_007194.3:c.1632+7T>C	not provided		literature only	not provided			GeneDx	GDX:407490|MeSH:D009386	SCV000211026	NM_007194.3:c.*7T>C	Benign	Sep  8 2014 12:00:00:000AM	clinical testing	Neoplastic Syndromes, Hereditary	Hereditary cancer-predisposing syndrome	The variant is found in ENDOM-HEREDIC,BR-OV-HEREDIC panel(s).	-1
	132887	136636	NM_003156.3(STIM1):c.910C>T (p.Arg304Trp)	Institute of Human Genetics RWTH University Hospital Aachen	NM_003156.3:c.910C>T|HGAC	SCV000154183	NM_003156.3:c.910C>T	not provided		literature only	not provided			OMIM	605921.0008_STORMORKEN SYNDROME	SCV000172228		Pathogenic	Jul 11 2014 12:00:00:000AM	literature only	STORMORKEN SYNDROME	Stormorken syndrome		-1